TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1920344

Group type: EXPERIMENTAL
Intervention: Nicardipine 60 or 90 mg/day
Number of subjects: 243

Group type: COMPARATOR
Intervention: Propranolol 90-240 mg/day
Number of subjects: 243
Study: 6136290

Group type: EXPERIMENTAL
Intervention: Midazolam (0.07 mg kg‐1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Diazepam (0.15 mg kg‐1)
Number of subjects: 100
Study: 31350681

Group type: EXPERIMENTAL
Intervention: Text-messaging
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Peer navigation
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study: 28973670

Group type: EXPERIMENTAL
Intervention: Guided group (mhealth app)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Freehand group
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 139
Study: 26868210

Group type: EXPERIMENTAL
Intervention: Asthma diagnosed <1 year or 6 months before the index date
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bronchodilator use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-asthma drug prescription
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-asthmatic medication use in Viborg vascular trial
Number of subjects: 0
Study: 25785278

Group type: EXPERIMENTAL
Intervention: Management of borderline GDM (lifestyle changes including diet and exercise)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Planned lifestyle changes (diet and/or exercise)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Motivators for lifestyle change
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Barriers to lifestyle change
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Concern after diagnosis
Number of subjects: 22
Study: 23058097

Group type: EXPERIMENTAL
Intervention: Bevacizumab added to XELOX (oxaliplatin plus capecitabine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bevacizumab added to FOLFOX-4 (oxaliplatin plus 5-fluorouracil and folinic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: XELOX (oxaliplatin plus capecitabine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFOX-4 (oxaliplatin plus 5-fluorouracil and folinic acid)
Number of subjects: 0
Study: 20634651

Group type: EXPERIMENTAL
Intervention: Ezetimibe combined with statins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Statins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fibrates and niacin
Number of subjects: 0
Study: 18637311

Group type: EXPERIMENTAL
Intervention: Haemodynamic contrast-enhanced ultrasound assessment
Number of subjects: 50
Study: 16037885

Group type: EXPERIMENTAL
Intervention: Cyclists (ACE and CKMM genotypes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Controls (ACE and CKMM genotypes)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Runners (ACE and CKMM genotypes)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cyclists and Controls (D allele)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Runners (I allele)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CKK-MM-NcoI
Number of subjects: 50
Study: 12388959

Group type: EXPERIMENTAL
Intervention: Acetaminophen 650 mg every 4 hours
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo every 4 hours
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 10630346

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment twice weekly for 4 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 75
Study: 7770313

Group type: EXPERIMENTAL
Intervention: Desipramine (25 mg four times daily)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Clonidine (0.05 mg four times daily)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 37
Study: 2180268

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg once daily
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg once daily
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg twice daily
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg twice daily
Number of subjects: 8245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin (all doses)
Number of subjects: 8245
Study: 6127906

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Mepindolol sulphate
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 2
Study: 30929268

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 29202751

Group type: EXPERIMENTAL
Intervention: Walnut-enriched reduced-energy diet (15% of energy)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard reduced-energy-density diet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Walnut-enriched reduced-energy diet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 25546052

Group type: EXPERIMENTAL
Intervention: Oxymetazoline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 22872323

Group type: EXPERIMENTAL
Intervention: 30 ml simple olive oil (OO)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 30 ml EGCG-supplemented olive oil (OO)
Number of subjects: 82
Study: 21167906

Group type: EXPERIMENTAL
Intervention: Cognitive-emotional sensitization through repetitive presentation of disorder-related pictures
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 25
Study: 19880052

Group type: EXPERIMENTAL
Intervention: research-HSA (r-HSA)
Number of subjects: 191

Group type: COMPARATOR
Intervention: clinical HSA (c-HSA)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: research-HSA (r-HSA) and clinical HSA (c-HSA)
Number of subjects: 191
Study: 19926959

Group type: EXPERIMENTAL
Intervention: Enhanced labor ward-based services for PMTCT (opt-in HIV testing and NVP administration)
Number of subjects: 7664

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 7664

Group type: EXPERIMENTAL
Intervention: Enhanced labor ward-based services for PMTCT
Number of subjects: 7664
Study: 16111901

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SNP (sodium nitro-prusside)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11818429

Group type: EXPERIMENTAL
Intervention: Treadmill walking program (6 months)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non-walking control group
Number of subjects: 16
Study: 10194693

Group type: EXPERIMENTAL
Intervention: Prophylactic tropisetron 5 mg orally before anesthesia
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study: 8531404

Group type: EXPERIMENTAL
Intervention: Endoscopic examination
Number of subjects: 31
Study: 2325217

Group type: COMPARATOR
Intervention: Unna's compressive boots
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Unna's compressive boots and sclerotherapy with 3% sodium tetradecyl sulfate (Sotradecol)
Number of subjects: 28
Study: 7373798

Group type: EXPERIMENTAL
Intervention: Self-care book and optional seminar
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Self-care book with financial incentive ($50 for reduced visits)
Number of subjects: 699

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 699
Study: 29934378

Group type: EXPERIMENTAL
Intervention: Gynaecology Teaching Associate (GTA) teaching
Number of subjects: 492

Group type: COMPARATOR
Intervention: Conventional manikin teaching
Number of subjects: 492
Study: 27451818

Group type: EXPERIMENTAL
Intervention: DOTS Category I treatment plus prednisolone 1mg/kg for first 4 weeks, then tapered down
Number of subjects: 120

Group type: COMPARATOR
Intervention: DOTS Category I treatment plus placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DOTS Category I treatment plus prednisolone
Number of subjects: 120
Study: 24213955

Group type: EXPERIMENTAL
Intervention: 3 hours of rehabilitation treatment including aerobic exercise for 28 days (Group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Not therapy (control; Group 2)
Number of subjects: 30
Study: 22421093

Group type: EXPERIMENTAL
Intervention: Limbal marked group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Unmarked group
Number of subjects: 200
Study: 20090328

Group type: EXPERIMENTAL
Intervention: Resin infiltration (etched for 5 s with 37% H(3)PO(4) and infiltrated twice for 60 s)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Positive control (fissure sealant applied to one lesion)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Untreated control (no treatment applied)
Number of subjects: 104
Study: 18565980

Group type: EXPERIMENTAL
Intervention: FROP-Com
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUG)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Functional Reach (FR)
Number of subjects: 344
Study: 16002181

Group type: EXPERIMENTAL
Intervention: Sustained-release chlorhexidine dressing
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard dressing regimen (control)
Number of subjects: 112
Study: 11974977

Group type: EXPERIMENTAL
Intervention: Pericranial injection of 10 x 20 MU DYSPORT
Number of subjects: 21

Group type: COMPARATOR
Intervention: Injection of isotonic saline (placebo)
Number of subjects: 21
Study: 10527096

Group type: EXPERIMENTAL
Intervention: Plaster cast socket with silicone sleeve
Number of subjects: 56

Group type: COMPARATOR
Intervention: Elastic compression bandages (control)
Number of subjects: 56
Study: 7574314

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (lower limb surgery)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Open cholecystectomy (OC)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: All groups (OC, LC, control)
Number of subjects: 49
Study: 2188845

Group type: EXPERIMENTAL
Intervention: 125 micrograms cyclopenthiazide
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 500 micrograms cyclopenthiazide
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6971940

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory analgesics
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31202921

Group type: EXPERIMENTAL
Intervention: Ceftazidime/avibactam (CAZ‐AVI)
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 5000
Study: 28753799

Group type: EXPERIMENTAL
Intervention: CellDetect assay
Number of subjects: 217

Group type: COMPARATOR
Intervention: BTA stat
Number of subjects: 217

Group type: COMPARATOR
Intervention: Standard urine cytology
Number of subjects: 217

Group type: COMPARATOR
Intervention: True negative cases
Number of subjects: 217
Study: 26964827

Group type: EXPERIMENTAL
Intervention: Nebulized magnesium sulfate (3 ml of 260 mmol/L solution every 20 to 60 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group treated with nebulized saline as a placebo in addition to standard protocol
Number of subjects: 50
Study: 25251929

Group type: EXPERIMENTAL
Intervention: Hypoxic exercise training (16.5% O2, n=10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normoxic exercise training (21% O2, n=9)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups (Hypoxic and Normoxic)
Number of subjects: 19
Study: 21981682

Group type: EXPERIMENTAL
Intervention: Tadalafil 2.5 mg
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg
Number of subjects: 606

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 606
Study: 20564607

Group type: EXPERIMENTAL
Intervention: Alverine citrate 120 mg capsule
Number of subjects: 0
Study: 17013645

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (1 mg intravenously every 3 months for a total of four doses)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (20 age- and sex-matched healthy blood donors)
Number of subjects: 29
Study: 16119667

Group type: EXPERIMENTAL
Intervention: Support Team Assessment Schedule (STAS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rotterdam Symptom Checklist (RSCL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Assessment of physical state after treatment
Number of subjects: 50
Study: 11124916

Group type: EXPERIMENTAL
Intervention: Oral vitamin A supplementation (5000 IU/day)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 9701528

Group type: EXPERIMENTAL
Intervention: Trimebutine (50 mg intravenous injection)
Number of subjects: 15
Study: 8029677

Group type: EXPERIMENTAL
Intervention: Preoperative intravenous cholangiography
Number of subjects: 100

Group type: COMPARATOR
Intervention: No preoperative intravenous cholangiography
Number of subjects: 100
Study: 2597447

Group type: EXPERIMENTAL
Intervention: PTFE-sil
Number of subjects: 30

Group type: COMPARATOR
Intervention: PTFE
Number of subjects: 30
Study: 30875348

Group type: EXPERIMENTAL
Intervention: Lapatinib 1000 mg daily with eribulin 1.23 mg/m (split-dose arm) days 1+8 every 21 days
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Eribulin 1.76 mg/m (3-weekly arm) day 1 every 21 days
Number of subjects: 43
Study: 30695420

Group type: EXPERIMENTAL
Intervention: Qingshen Granule (QG), 1 package each time, 3 times per day for 8 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Basic treatment of Western medicine (WM) and retention enema of Chinese medicine (CM)
Number of subjects: 63
Study: 26089547

Group type: EXPERIMENTAL
Intervention: Exercise group (60 min cycling at 70% of peak oxygen uptake)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 20
Study: 23489396

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 1254

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 1254
Study: 21624541

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (6 g/day for a mean of 40 ± 12 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 19364997

Group type: EXPERIMENTAL
Intervention: ATP III intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control intervention (JNC‐7)
Number of subjects: 68
Study: 16682588

Group type: EXPERIMENTAL
Intervention: Simvastatin (daily administration for 7 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Simvastatin (90 minutes after administration)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Simvastatin (90 minutes and 7 days after administration)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Simvastatin (after 7 days)
Number of subjects: 12
Study: 15292751

Group type: COMPARATOR
Intervention: Concentric training at 30 degrees x s(‐1) (G1)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Concentric training at 90 degrees x s(‐1) (G2)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Eccentric training at 30 degrees x s(‐1) (G3)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Eccentric training at 90 degrees x s(‐1) (G4)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Training within 30‐60 degrees of knee flexion (all groups)
Number of subjects: 55
Study: 11406520

Group type: EXPERIMENTAL
Intervention: D2E7 (anti-TNF monoclonal antibody)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 9761518

Group type: COMPARATOR
Intervention: CAPD
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CCPD
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TPD (tidal 50%)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TPD (tidal 25%)
Number of subjects: 45
Study: 7810814

Group type: EXPERIMENTAL
Intervention: Ointment containing two antibiotics
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Ointment containing one antibiotic plus hydrocortisone
Number of subjects: 77

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 77
Study: 2974095

Group type: EXPERIMENTAL
Intervention: Synthetic human ANP (102-126) at 0.015 microgram/kg/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Synthetic human ANP (102-126) at 0.20 microgram/kg/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Synthetic human ANP (102-126)
Number of subjects: 8
Study: 31903697

Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL
Number of subjects: 0
Study: 29229352

Group type: EXPERIMENTAL
Intervention: Intracranial pressure monitoring in severe TBI
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Higher Glasgow Coma Scale motor score
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Epidural hematoma
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Advanced age
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Cisternal effacement
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Study site
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Race
Number of subjects: 550
Study: 27513601

Group type: EXPERIMENTAL
Intervention: Ethmoid crest resection during electrocoagulation of the sphenopalatine artery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no ethmoid crest resection)
Number of subjects: 42
Study: 26571890

Group type: EXPERIMENTAL
Intervention: Combined therapy of auricular point sticking and Xiaopijian
Number of subjects: 91

Group type: COMPARATOR
Intervention: Xiaopijian (control group)
Number of subjects: 91
Study: 24260195

Group type: EXPERIMENTAL
Intervention: FMP2.1/AS02A vaccine
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control rabies vaccine
Number of subjects: 400
Study: 21553262

Group type: EXPERIMENTAL
Intervention: Low-frequency stimulation (LFS) applied to the low back (ExpBack)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low-frequency stimulation (LFS) applied to the center of the RF (ExpArm)
Number of subjects: 33
Study: 18450889

Group type: EXPERIMENTAL
Intervention: Low-oxygen group (fraction of inspired oxygen: 30%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-oxygen group (fraction of inspired oxygen: 90%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-oxygen group
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-oxygen group
Number of subjects: 0
Study: 16926619

Group type: EXPERIMENTAL
Intervention: Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders (CYBOCS-PDD)
Number of subjects: 172
Study: 12151898

Group type: EXPERIMENTAL
Intervention: Compression hip screw
Number of subjects: 426

Group type: COMPARATOR
Intervention: Gamma nail
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 426
Study: 10546006

Group type: EXPERIMENTAL
Intervention: Simvastatin treatment
Number of subjects: 3438
Study: 7799013

Group type: EXPERIMENTAL
Intervention: MVPP
Number of subjects: 89

Group type: COMPARATOR
Intervention: ChIVPP/EVA
Number of subjects: 89
Study: 1689740

Group type: EXPERIMENTAL
Intervention: Finasteride (doses of 0.2-80 mg)
Number of subjects: 0
Study: 520385

Group type: EXPERIMENTAL
Intervention: EEG alpha rhythm and refractory period model
Number of subjects: 20
Study: 6866590

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) in a high-calcium and vitamin D-containing formula (50% of fat as MCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Long-chain triglycerides in a similar formula (control group)
Number of subjects: 20
Study: 30696786

Group type: EXPERIMENTAL
Intervention: 2017 agreement language
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: Stricter language
Number of subjects: 820

Group type: COMPARATOR
Intervention: Original NAS advertising text
Number of subjects: 820
Study: 30400934

Group type: EXPERIMENTAL
Intervention: 3-month malaria chemoprevention (PMC) with monthly 3-day treatment courses of dihydroartemisinin-piperaquine at 2, 6, and 10 weeks after discharge
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Standard in-hospital care plus a single 3-day treatment course with artemether-lumefantrine at discharge
Number of subjects: 1040
Study: 27634079

Group type: EXPERIMENTAL
Intervention: Core strength training (CST)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study: 24799520

Group type: EXPERIMENTAL
Intervention: Initial antiepileptic treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EEG characteristics prior to treatment
Number of subjects: 0
Study: 22381025

Group type: EXPERIMENTAL
Intervention: Encapsulated supplement of fruit and vegetable juice concentrate (FVJC) for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo capsules for 6 months
Number of subjects: 30
Study: 20847903

Group type: EXPERIMENTAL
Intervention: Tailored Activity Program (TAP)
Number of subjects: 60
Study: 18046109

Group type: EXPERIMENTAL
Intervention: Irbesartan/HCTZ 300/25 mg once daily for 7 to 8 weeks
Number of subjects: 796
Study: 15272291

Group type: EXPERIMENTAL
Intervention: Blood pressure measurement in the eye clinic
Number of subjects: 106

Group type: COMPARATOR
Intervention: Home blood pressure measurement (HBPM)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Ambulatory blood pressure measurement (ABPM)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Diabetic clinic BP measurements
Number of subjects: 106

Group type: COMPARATOR
Intervention: Tropicamide 1% and phenylephrine 2.5% eye drops
Number of subjects: 106
Study: 12389836

Group type: EXPERIMENTAL
Intervention: Systematic detection and multidisciplinary care of delirium
Number of subjects: 227

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 227